- Q1 2024 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024$1.19 (-2.46%)Earnings
- Q4 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2024$1.48 (+0.68%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2023$0.8705 (+3.51%)Earnings
- Rigel Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2023$1.33 (-3.62%)Earnings
- Rigel Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023$1.14 (-4.20%)Earnings
- Q4 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 07, 2023$1.47 (-3.29%)Earnings
- Rigel Pharmaceuticals Inc To Discuss The FDA Approval of REZLIDHIA Call TranscriptDec 01, 2022
- Q3 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022$0.7255 (+3.23%)Earnings
- Q2 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2022$1.3 (+7.44%)Earnings
- Rigel Pharmaceuticals Inc to Discuss FORWARD Study Results TranscriptJun 08, 2022
- Q1 2022 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2022$2.48 (+0.81%)Earnings
- Q4 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022$2.51Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021$3.57 (+0.85%)Earnings
- Rigel Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021$3.78 (-5.97%)Earnings
- Rigel Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 18, 2021
- Q1 2021 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$3.47 (+0.87%)Earnings
- Rigel Pharmaceuticals Inc Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19 -Corporate Call TranscriptApr 13, 2021
- Q4 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptMar 02, 2021$4.31 (-3.69%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$2.74 (+1.48%)Earnings
- Rigel Pharmaceuticals Inc at Citi BioPharma Conference (Virtual)- Panel: State of Play for COVID-19 Therapeutics TranscriptSep 09, 2020
- Q2 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2020$2.46 (+1.23%)Earnings
- Rigel Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 14, 2020
- Q1 2020 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2020$1.96 (+5.95%)Earnings
- Q4 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2020$2.04 (-5.99%)Earnings
- Rigel Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Q3 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019$2.17 (+0.93%)Earnings
- Rigel Pharmaceuticals Inc Investor and Analyst Call TranscriptOct 23, 2019
- Editas Medicine Inc, Apellis Pharmaceuticals Inc and Rigel Pharmaceuticals Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$2.17 (+3.33%)Earnings
- Q1 2019 Rigel Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2019$2.32 (-2.52%)Earnings
- Q4 2018 Rigel Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2019$2.19 (-3.10%)Earnings
Q1 2019 Rigel Pharmaceuticals Inc Earnings Call Transcript
Good afternoon and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter of 2019. (Operator Instructions) I would like to remind you that this call is being recorded for replay purposes from Rigel's website. (Operator Instructions) And now I will turn this conference over to our first speaker, Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel.
Welcome to our financial results and business update conference call. The financial press release for the first quarter of 2019 was issued a short while ago and can be viewed, along with the accompanying slides for this presentation, in the news and events section of our Investor Relations page on our website at www.rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our financial outlook and our plans and timing for regulatory
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)